{
  "name": "Fibrates and nicotinic acid",
  "title": "Total cost of prescriptions for fibrates and nicotinic acid per 1000 registered patients",
  "description": "Total cost of prescriptions for fibrates and nicotinic acid per 1000 registered patients",
  "numerator_short": "Cost of selected items (£)",
  "denominator_short": "1000 patients",
  "y_label": "Cost (£) per 1000 patients",
  "why_it_matters": [
    "NICE guideline <a href='https://www.nice.org.uk/guidance/ng238/chapter/Recommendations#lipid-lowering-treatments-that-should-not-be-used-or-not-used-routinely' target='_blank'>NG238 (cardiovascular disease: risk assessment and reduction, including lipid modification)</a> recommends that ",
    "fibrates and nicotinic acid should not be routinely offered to patients for the primary or secondary prevention of cardiovascular disease (CVD). ",
    "This guidance does not apply to people with familial hypercholesterolaemia, which is covered by <a href='https://www.nice.org.uk/guidance/cg71' target='_blank'> separate NICE guidance</a>."
  ],
  "tags": [
    "cardiovascular",
    "core",
    "efficacy",
    "nice"
  ],
  "url": null,
  "is_percentage": false,
  "is_cost_based": true,
  "low_is_good": true,
  "numerator_type": "bnf_cost",
  "numerator_bnf_codes_filter": [
    "0212000A0 # Acipimox",
    "0212000D0 # Bezafibrate",    
    "021200010 # Ciprofibrate",
    "0212000P0 # Fenofibrate",
    "0212000Q0 # Gemfibrozil",
    "0212000U0 # Nicotinic Acid",    
    "0212000AE # Nicotinic Acid/Laropiprant"
  ],
  "denominator_type": "list_size",
  "authored_by": "richard.croker@phc.ox.ac.uk",
  "checked_by": "andrew.brown@phc.ox.ac.uk",
  "date_reviewed": "2024-01-02",
  "next_review": "2026-01-02",
  "measure_complexity": "low",
  "measure_type": "bnf_code",
  "radar_exclude": false
}
